Search clinical trials for: Xeliri

Total 19 results

Zhejiang Cancer Hospital

Recruiting

A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status

Radiation | Toripalimab

China
National University Hospital, Singapore
The N.1 Institute for Health (N.1)

Recruiting

PRECISE CURATE.AI Pilot Clinical Trial

Solid Tumor

Singapore
Jiangsu Cancer Institute & Hospital

Recruiting

A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Pia Osterlund

Recruiting

Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Finland
Cancer Institute and Hospital, Chinese Academy...
Henan Cancer Hospital; Beijing Hospital; Jiangsu Cancer Institute & Hospital; Liaoning...

Completed

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Prof. Dr. Werner Scheithauer

Completed

Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer (PASSION)

Metastatic Colorectal Cancer

Austria
University Health Network, Toronto
Hoffmann-La Roche

Completed

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Colorectal Cancer

Canada
Epidemiological and Clinical Research Information...

Completed

A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (AXEPT)

Gastrointestinal Neoplasms | Digestive System Neoplasms | Neoplasm Metastasis | Colorectal Neoplasms | Intestinal Neoplasms

Japan
Harbin Medical University
Sun Yat-sen University; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Colorectal Neoplasms | Chemotherapy

China
Harbin Medical University
Sun Yat-sen University; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Colorectal Neoplasms | Chemotherapy

China
H. Lee Moffitt Cancer Center and Research Institute
Roche Pharma AG

Terminated

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Adenocarcinoma | Colon Cancer

United States
University Hospital of Crete

Terminated

Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment

Metastatic Colorectal Cancer

Greece
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer (SETICC)

Colorectal Cancer

Spain
Grupo Hospital de Madrid

Unknown

Angiogenic Switch in Patients With Colorectal Cancer (ANGIOSWITCH)

Colorectal Cancer

Spain
Sun Yat-sen University

Unknown

Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects

Non-steroidal Anti-inflammatory Drug Adverse Reaction

China
Samsung Medical Center

Unknown

Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer

Colorectal Cancer

Korea, Republic of
Fudan University

Completed

Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer

Colorectal Cancer

China
Fudan University

Unknown

wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients

Colorectal Cancer

China
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC

Colorectal Cancer

Greece

Search clinical trials for: Xeliri

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations